Expression of the human erythrocyte glucose transporter in transitional cell carcinoma of the bladder

Expression of the human erythrocyte glucose transporter in transitional cell carcinoma of the bladder
复制标题

DOI:
10.1016/s0090-4295(99)00474-4
复制
发表时间:
2000-03-01
期刊:
影响因子:
2.1
通讯作者:
Kim, YW
Kim, YW
中科院分区:
医学4区
文献类型:
--
作者:
Chang, SG;Lee, SJ;Kim, YW

文献摘要

被引文献

相似文献

目标。先前的研究表明,在肿瘤中,葡萄糖的摄取和使用比在正常细胞和组织中更为普遍。我们推测人红细胞葡萄糖转运蛋白(Glut-1)在膀胱移行细胞癌(TCC)中表达升高,其表达程度可能与恶性程度相关。对正常膀胱组织(5例)、良性乳头状瘤组织(10例)、浅表肿瘤组织(48例)、侵袭性肿瘤组织(31例)的Glut-1蛋白进行免疫染色。采用免疫反应性分级系统:肿瘤细胞无免疫反应性= 0;小于10%的肿瘤细胞免疫反应性= 1+;10% ~ 50%的肿瘤细胞免疫反应性= 2+;大于50%的肿瘤细胞免疫反应性= 3+。Glut-1蛋白的免疫染色在正常膀胱和良性乳头瘤样本中未表达,但在63.0%(73例中的46例)的TCC样本中表达。在Glut-1蛋白的表达模式中,浅表TCC呈局灶性染色,浸润性TCC在肿瘤巢中呈弥漫性染色。浸润性TCC中Glut-1蛋白的表达水平明显高于浅表性TCC (P = 0.002),高核级TCC中Glut-1蛋白表达水平明显高于低核级TCC (P = 0.007)。在表面TCC样品中。膀胱肿瘤复发率与Glut-1蛋白表达无显著相关性(P = 0.40)。我们的研究结果表明,Glut-1蛋白在正常膀胱粘膜和良性病变中不表达,Glut-1蛋白的表达与膀胱TCC的肿瘤进展密切相关,而Glut-1蛋白的表达与浅表性膀胱TCC的复发率无关。(C) 2000, Elsevier Science Inc.;
Objectives. It has previously been shown that glucose uptake and use is more prevalent in carcinomas than in normal cei Is and tissues. We hypothesized that human erythrocyte glucose transporter (Glut-1) expression is increased in bladder transitional cell carcinoma (TCC) and that the grade of expression might correlate with the degree of malignancy.Methods. Immunostaining of Glut-1 protein was studied in normal bladder (5 cases), benign papilloma (10 cases), superficial tumor (48 cases), and invasive tumor (31 cases) tissue. The immunoreactivity grading system used was as follows: absence of immunoreactivity in tumor cell = 0; less than 10% of the tumor cells immunoreactive = 1+; 10% to 50% of the tumor cells immunoreactive = 2+; and greater than 50% of the tumor cells immunoreactive = 3+.Results. Immunostaining of Glut-1 protein was not expressed in the normal bladder or benign papilloma samples, but it was expressed in 63.0% (46 of 73) of the TCC samples. In the pattern of expression of Glut-1 protein, superficial TCC was stained focally, but invasive TCC was stained diffusely in the tumor nests. The grade of Glut-1 protein expression increased more significantly in the invasive TCC than in the superficial TCC samples (P = 0.002) and more significantly in the high nuclear grade than in the low nuclear grade samples (P = 0.007). In the superficial TCC samples. the bladder tumor recurrence rate did not significantly correlate with Glut-1 protein expression (P = 0.40).Conclusions. Our results suggest that the Glut-1 protein is not expressed in normal bladder mucosa and benign lesions, that Glut-1 protein expression is strongly associated with neoplastic progression in bladder TCC, and that Glut-1 expression does not correlate with the recurrence rate in superficial bladder TCC. (C) 2000, Elsevier Science Inc.